Administration of a multistrain probiotic product (VSL#3) to women in the perinatal period differentially affects breast milk beneficial microbiota in relation to mode of delivery.

Pharmacological research
Q1
May 2015
Citations:62
Influential Citations:5
Interventional (Human) Studies
84
S2 Icon

Abstract

No abstract available